Table 4.
Tick counts in study 2
Group | Dog ID | SDneg+1mo 34/SD7mo 221 (in situ counts 48 h p.i.) | SDneg+1mo 37/SD7mo 224 (5 days p.i.) |
---|---|---|---|
Non-treated group (group 1) | TJI-2 | 14 | 32 |
ISK-2 | 11 | 25 | |
VPI-2 | 4 | 38 | |
TII-2 | 25 | 46 | |
EXJ-2 | 11 | 34 | |
KTL-2 | 12 | 33 | |
YOO-2 | 15 | 34 | |
AFO-2 | 17 | 38 | |
WVO-2 | 18 | 39 | |
KIP-2 | 8 | 29 | |
Arithm. mean | 13.5 | 34.8 | |
1mo-Seresto®-treated group (group 2) | UBL-2, VOI-2, BHP-2, WJP-2, ETJ-2, QVJ-2, GIJ-2, GYK-2, IUK-2, ZFP-2 | All dogs 0 | All dogs 0 |
Arithm. mean | 0 | 0 | |
7mo-Seresto®-treated group (group 3) | XQP-2, ZYG-2, GAG-2, OYJ-2, TVQ-2, VEI-2, OIJ-2, PIJ-2, BJH-2, ITK-2 | All dogs 0 | All dogs 0 |
Arithm. mean | 0 | 0 |
SD, study day; p.i., post infestationem